The incidence of ductal carcinoma in situ (DCIS) rose rapidly when the NHS Breast Screening Programme (NHSBSP) started in 1988. Some authorities consider that this represents both over-diagnosis and ...
Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines Between 1994 and 2008, 147 patients with recurrent HGG were treated with H-SRT (median dose, 35 ...
High-grade gliomas represent a significant source of cancer-related death, and usually recur despite treatment. In this analysis of current brain tumor medicine, we review diagnosis, standard ...
TLX101 treatment in recurrent high-grade glioma showed a median overall survival of 12.4 months, with no serious side effects reported. The study supports the potential for higher therapeutic doses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback